About
Sensulin is a biopharmaceutical company developing glucose-responsive insulin therapies aimed at reducing hypoglycemia risk and the burden of daily insulin injections in patients with type 1 and type 2 diabetes.
Explore Sensulin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.